Company’s 36-month beta value is 0.67.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for WINT is 0.42M, and currently, short sellers hold a 0.61% ratio of that floaft. The average trading volume of WINT on May 06, 2024 was 17.11K shares.
WINT) stock’s latest price update
The stock of Windtree Therapeutics Inc (NASDAQ: WINT) has increased by 14.09 when compared to last closing price of 4.33.Despite this, the company has seen a loss of -5.54% in its stock price over the last five trading days. Invezz reported 2024-04-22 that Windtree Therapeutics Inc (NASDAQ: WINT) is down nearly 20% on Monday even though there hasn’t been any specific news that may have caused that decline. Here’s what may be weighing on Windtree Therapeutics stock Investors may be continuing to respond to a few updates that $WINT has posted in recent days.
WINT’s Market Performance
Windtree Therapeutics Inc (WINT) has seen a -5.54% fall in stock performance for the week, with a -28.46% decline in the past month and a -31.39% plunge in the past quarter. The volatility ratio for the week is 13.58%, and the volatility levels for the past 30 days are at 14.76% for WINT. The simple moving average for the past 20 days is -20.11% for WINT’s stock, with a -65.45% simple moving average for the past 200 days.
Analysts’ Opinion of WINT
Many brokerage firms have already submitted their reports for WINT stocks, with Ladenburg Thalmann repeating the rating for WINT by listing it as a “Buy.” The predicted price for WINT in the upcoming period, according to Ladenburg Thalmann is $12.25 based on the research report published on June 26, 2020 of the previous year 2020.
WINT Trading at -22.93% from the 50-Day Moving Average
After a stumble in the market that brought WINT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.93% of loss for the given period.
Volatility was left at 14.76%, however, over the last 30 days, the volatility rate increased by 13.58%, as shares sank -35.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.29% lower at present.
During the last 5 trading sessions, WINT fell by -5.54%, which changed the moving average for the period of 200-days by -81.58% in comparison to the 20-day moving average, which settled at $6.05. In addition, Windtree Therapeutics Inc saw -61.83% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at WINT starting from Fraser Craig, who purchase 2,500 shares at the price of $1.02 back on Sep 27 ’23. After this action, Fraser Craig now owns 57,877 shares of Windtree Therapeutics Inc, valued at $2,550 using the latest closing price.
Fraser Craig, the President and CEO of Windtree Therapeutics Inc, purchase 2,500 shares at $0.90 during a trade that took place back on Sep 26 ’23, which means that Fraser Craig is holding 55,377 shares at $2,250 based on the most recent closing price.
Stock Fundamentals for WINT
The total capital return value is set at -0.72. Equity return is now at value -302.78, with -57.68 for asset returns.
Based on Windtree Therapeutics Inc (WINT), the company’s capital structure generated 0.82 points at debt to capital in total, while cash flow to debt ratio is standing at -0.86. The debt to equity ratio resting at 4.62. The interest coverage ratio of the stock is -411.94.
Currently, EBITDA for the company is -17.46 million with net debt to EBITDA at -0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.35.
Conclusion
In a nutshell, Windtree Therapeutics Inc (WINT) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
